MoneyWorks4Me

Indoco Remedies informs about press release

29 Jul 2026 Evaluate
Indoco Remedies has informed that it enclosed copies of the newspaper advertisement published today 29th July, 2026 in Business Standard (All India Editions) (English Newspaper) and Mumbai Lakshadeep (Marathi Newspaper) with respect to the extract of Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter Ended 30th June, 2026.

The above information is a part of company’s filings submitted to BSE.

Indoco Remedies Share Price

221.60 -0.25 (-0.11%)
07-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1949.00
Dr. Reddys Labs. 1172.00
Cipla 1472.00
Lupin 2360.00
Zydus Lifesciences 1115.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: